Pneumonia Diagnostic - Global Market Outlook (2016-2022)

  • ID: 4428343
  • Report
  • Region: Global
  • 152 pages
  • Stratistics Market Research Consulting Pvt Ltd
UP TO OFF
until Jan 31st 2019
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott
  • Beckman Coulter Inc
  • bioMerieux
  • Cepheid
  • Elitech Group
  • Merck & Co
  • MORE
Factors such as developing innovative technologies and products, increasing patient awareness and improving productivity of diagnosing pneumonia are boosting the market growth. Advent of new drugs and advance treatment facilitates are going to provide new market opportunities to emerge. However, there is n-particular treatment available to detect the pneumonia as its symptoms coincide with diseases like bronchitis, common cold and asthma which are restraining the market growth.

Chest X-ray and CT scan are generally recommended for the diagnosis of pneumonia diagnostics. North America is the largest market due to increasing resistance to multi drugs by microorganisms and increasing geriatric population. Asia Pacific is anticipated to be the fastest growing market owing to prevalence of disease in several countries including India, Japan and Bangladesh. Additionally, high awareness and disposable income are potential growth factors.

Some of the key players in global Pneumonia Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Therm-Fisher Scientific, GlaxoSmithCline and Merck & Co.

Treatments Covered:
  • Vaccines
  • PCV13
  • PPV23
  • Antibiotics
  • Amoxicillin
  • Cephalosporin
  • Penicillin
  • Tetracycline
  • Vancomycin
  • Fluoroquinolones
Tests Covered:
  • Blood Test
  • Bronchoscopy
  • Chest X ray
  • Chest Computed Tomography (CT) Scan
  • Pulse Oximetry
  • Pleural Fluid Culture
  • Sputum Test
End Users Covered:
  • Clinics
  • Diagnostic Centres
  • Hospitals
  • Commercial/Private Labs
  • Other End Users
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Beckman Coulter Inc
  • bioMerieux
  • Cepheid
  • Elitech Group
  • Merck & Co
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pneumonia Diagnostic Market, By Treatment
5.1 Introduction
5.2 Vaccines
5.2.1 PCV13
5.2.2 PPV23
5.3 Antibiotics
5.3.1 Amoxicillin
5.3.2 Cephalosporin
5.3.3 Penicillin
5.3.4 Tetracycline
5.3.5 Vancomycin
5.3.6 Fluoroquinolones

6 Global Pneumonia Diagnostic Market, By Test
6.1 Introduction
6.2 Blood Test
6.3 Bronchoscopy
6.4 Chest X ray
6.5 Chest Computed Tomography (CT) Scan
6.6 Pulse Oximetry
6.7 Pleural Fluid Culture
6.8 Sputum Test

7 Global Pneumonia Diagnostic Market, By End User
7.1 Introduction
7.2 Clinics
7.3 Diagnostic Centres
7.4 Hospitals
7.5 Commercial/Private Labs
7.6 Other End Users

8 Global Pneumonia Diagnostic Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Abbott
10.2 Affymetrix
10.3 Beckman Coulter Inc
10.4 Becton Dickinson
10.5 bioMerieux
10.6 Bio-Rad
10.7 Cepheid
10.8 Diamedix
10.9 Elitech Group
10.10 Qiagen
10.11 Siemens
10.12 Thermo Fisher Scientific
10.13 GlaxoSmithCline
10.14 Merck & Co

List of Tables

Table 1 Global Pneumonia Diagnostic Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 3 Global Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 4 Global Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 5 Global Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 6 Global Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 7 Global Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 8 Global Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 9 Global Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 10 Global Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 11 Global Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 12 Global Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 13 Global Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 14 Global Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 15 Global Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 16 Global Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 17 Global Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 18 Global Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 19 Global Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 20 Global Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 21 Global Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 22 Global Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 23 Global Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 24 Global Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 25 Global Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 26 Global Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 27 North America Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 28 North America Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 29 North America Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 30 North America Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 31 North America Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 32 North America Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 33 North America Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 34 North America Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 35 North America Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 36 North America Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 37 North America Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 38 North America Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 39 North America Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 40 North America Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 41 North America Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 42 North America Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 43 North America Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 44 North America Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 45 North America Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 46 North America Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 47 North America Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 48 North America Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 49 North America Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 50 North America Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 51 North America Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 52 North America Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 53 Europe Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 54 Europe Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 55 Europe Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 56 Europe Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 57 Europe Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 58 Europe Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 59 Europe Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 60 Europe Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 61 Europe Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 62 Europe Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 63 Europe Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 64 Europe Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 65 Europe Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 66 Europe Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 67 Europe Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 68 Europe Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 69 Europe Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 70 Europe Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 71 Europe Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 72 Europe Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 73 Europe Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 74 Europe Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Table 75 Europe Pneumonia Diagnostic Market Outlook, By Diagnostic Centres (2014-2022) ($MN)
Table 76 Europe Pneumonia Diagnostic Market Outlook, By Hospitals (2014-2022) ($MN)
Table 77 Europe Pneumonia Diagnostic Market Outlook, By Commercial/Private Labs (2014-2022) ($MN)
Table 78 Europe Pneumonia Diagnostic Market Outlook, By Other End Users (2014-2022) ($MN)
Table 79 Asia Pacific Pneumonia Diagnostic Market Outlook, By Country (2014-2022) ($MN)
Table 80 Asia Pacific Pneumonia Diagnostic Market Outlook, By Treatment (2014-2022) ($MN)
Table 81 Asia Pacific Pneumonia Diagnostic Market Outlook, By Vaccines (2014-2022) ($MN)
Table 82 Asia Pacific Pneumonia Diagnostic Market Outlook, By PCV13 (2014-2022) ($MN)
Table 83 Asia Pacific Pneumonia Diagnostic Market Outlook, By PPV23 (2014-2022) ($MN)
Table 84 Asia Pacific Pneumonia Diagnostic Market Outlook, By Antibiotics (2014-2022) ($MN)
Table 85 Asia Pacific Pneumonia Diagnostic Market Outlook, By Amoxicillin (2014-2022) ($MN)
Table 86 Asia Pacific Pneumonia Diagnostic Market Outlook, By Cephalosporin (2014-2022) ($MN)
Table 87 Asia Pacific Pneumonia Diagnostic Market Outlook, By Penicillin (2014-2022) ($MN)
Table 88 Asia Pacific Pneumonia Diagnostic Market Outlook, By Tetracycline (2014-2022) ($MN)
Table 89 Asia Pacific Pneumonia Diagnostic Market Outlook, By Vancomycin (2014-2022) ($MN)
Table 90 Asia Pacific Pneumonia Diagnostic Market Outlook, By Fluoroquinolones (2014-2022) ($MN)
Table 91 Asia Pacific Pneumonia Diagnostic Market Outlook, By Test (2014-2022) ($MN)
Table 92 Asia Pacific Pneumonia Diagnostic Market Outlook, By Blood Test (2014-2022) ($MN)
Table 93 Asia Pacific Pneumonia Diagnostic Market Outlook, By Bronchoscopy (2014-2022) ($MN)
Table 94 Asia Pacific Pneumonia Diagnostic Market Outlook, By Chest X ray (2014-2022) ($MN)
Table 95 Asia Pacific Pneumonia Diagnostic Market Outlook, By Chest Computed Tomography (CT) Scan (2014-2022) ($MN)
Table 96 Asia Pacific Pneumonia Diagnostic Market Outlook, By Pulse Oximetry (2014-2022) ($MN)
Table 97 Asia Pacific Pneumonia Diagnostic Market Outlook, By Pleural Fluid Culture (2014-2022) ($MN)
Table 98 Asia Pacific Pneumonia Diagnostic Market Outlook, By Sputum Test (2014-2022) ($MN)
Table 99 Asia Pacific Pneumonia Diagnostic Market Outlook, By End User (2014-2022) ($MN)
Table 100 Asia Pacific Pneumonia Diagnostic Market Outlook, By Clinics (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Affymetrix
  • Beckman Coulter Inc
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • Elitech Group
  • Qiagen
  • Siemens
  • Thermo Fisher Scientific
  • GlaxoSmithCline
  • Merck & Co
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll